Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence

Nucleic Acids Research

Volumn 39, Issue 15, 2011, Pages 6741-6752

  Scarsdale, J Neel ^a,b   Webb, Heather D ^a   Ginder, Gordon D ^a,b,c   Williams Jr , David C ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METHYL CPG BINDING PROTEIN 2; PLASMA PROTEIN; RHO GLOBIN; UNCLASSIFIED DRUG; AVIAN PROTEIN; DNA BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHICKEN; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; DYNAMICS; ERYTHROID CELL; GENE SILENCING; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

ANIMALS; AVIAN PROTEINS; BASE SEQUENCE; CHICKENS; DNA; DNA METHYLATION; DNA-BINDING PROTEINS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 80052016907     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr262     Document Type: Article

References (65)

1. Straussman, R., Nejman, D., Roberts, D., Steinfeld, I., Blum, B., Benvenisty, N., Simon, I., Yakhini, Z. and Cedar, H. (2009) Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol., 16, 564-571.
2. Illingworth, R.S. and Bird, A.P. (2009) CpG islands-'a rough guide'. FEBS Lett., 583, 1713-1720.
3. Brock, M.V., Herman, J.G. and Baylin, S.B. (2007) Cancer as a manifestation of aberrant chromatin structure. Cancer J., 13, 3-8.
4. Jiang, Y., Dunbar, A., Gondek, L.P., Mohan, S., Rataul, M., O'keefe, C., Sekeres, M., Saunthararajah, Y. and Maciejewski, J.P. (2009) Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood, 113, 1315-1325.
5. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428. (Pubitemid 34587077)
6. Meehan, R.R., Lewis, J.D., McKay, S., Kleiner, E.L. and Bird, A.P. (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58, 499-507. (Pubitemid 19203534)
7. Hendrich, B. and Bird, A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18, 6538-6547. (Pubitemid 28500543)
8. Lopez-Serra, L., Ballestar, E., Fraga, M.F., Alaminos, M., Setien, F. and Esteller, M. (2006) A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res., 66, 8342-8346. (Pubitemid 44449141)
9. Fatemi, M. and Wade, P.A. (2006) MBD family proteins: reading the epigenetic code. J. Cell. Sci., 119, 3033-3037. (Pubitemid 44322117)
10. Chadwick, L.H. and Wade, P.A. (2007) MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein? Curr. Opin. Genet. Dev., 17, 121-125. (Pubitemid 46551717)
11. Kransdorf, E.P., Wang, S.Z., Zhu, S.Z., Langston, T.B., Rupon, J.W. and Ginder, G.D. (2006) MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells. Blood, 108, 2836-2845.
12. McGhee, J.D. and Ginder, G.D. (1979) Specific DNA methylation sites in the vicinity of the chicken b-globin genes. Nature, 280, 419-420. (Pubitemid 9233622)
13. Rupon, J.W., Wang, S.Z., Gaensler, K., Lloyd, J. and Ginder, G.D. (2006) Methyl binding domain protein 2 mediates g-globin gene silencing in adult human bYAC transgenic mice. Proc. Natl Acad. Sci. USA, 103, 6617-6622.
14. Singal, R., Wang, S.Z., Sargent, T., Zhu, S.Z. and Ginder, G.D. (2002) Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex. J. Biol. Chem., 277, 1897-1905. (Pubitemid 34968765)
15. Berger, J., Sansom, O., Clarke, A. and Bird, A. (2007) MBD2 is required for correct spatial gene expression in the gut. Mol. Cell. Biol., 27, 4049-4057. (Pubitemid 47011002)
16. Hutchins, A.S., Mullen, A.C., Lee, H.W., Sykes, K.J., High, F.A., Hendrich, B.D., Bird, A.P. and Reiner, S.L. (2002) Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell, 10, 81-91. (Pubitemid 34876564)
17. Lin, X. and Nelson, W.G. (2003) Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Cancer Res., 63, 498-504. (Pubitemid 36152513)
18. Bakker, J., Lin, X. and Nelson, W.G. (2002) Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem., 277, 22573-22580. (Pubitemid 34967234)
19. Singal, R., van Wert, J. and Bashambu, M. (2001) Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res., 61, 4820-4826. (Pubitemid 32691897)
20. Magdinier, F. and Wolffe, A.P. (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl Acad. Sci. USA, 98, 4990-4995. (Pubitemid 32397070)
21. Qian, J., Wang, Y.L., Lin, J., Yao, D.M., Xu, W.R. and Wu, C.Y. (2009) Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur. J. Haematol., 82, 119-123.
22. Sidiropoulos, M., Pampalakis, G., Sotiropoulou, G., Katsaros, D. and Diamandis, E.P. (2005) Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Tumour Biol., 26, 324-336. (Pubitemid 41619463)
23. Chatagnon, A., Ballestar, E., Esteller, M. and Dante, R. (2010) A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene. PLoS ONE, 5, e9665.
24. Klose, R.J., Sarraf, S.A., Schmiedeberg, L., McDermott, S.M., Stancheva, I. and Bird, A.P. (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell, 19, 667-678. (Pubitemid 41219442)
25. Clouaire, T., de Las Heras, J.I., Merusi, C. and Stancheva, I. (2010) Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res., 38, 4620-4634.
26. Sekimata, M. and Homma, Y. (2004) Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. Nucleic Acids Res., 32, 590-597. (Pubitemid 38263050)
27. Sekimata, M., Takahashi, A., Murakami-Sekimata, A. and Homma, Y. (2001) Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2. J. Biol. Chem., 276, 42632-42638.
28. Fraga, M.F., Ballestar, E., Montoya, G., Taysavang, P., Wade, P.A. and Esteller, M. (2003) The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res., 31, 1765-1774. (Pubitemid 36336578)
29. Ohki, I., Shimotake, N., Fujita, N., Jee, J., Ikegami, T., Nakao, M. and Shirakawa, M. (2001) Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell, 105, 487-497. (Pubitemid 32520854)
30. Ho, K.L., McNae, I.W., Schmiedeberg, L., Klose, R.J., Bird, A.P. and Walkinshaw, M.D. (2008) MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell, 29, 525-531. (Pubitemid 351282541)
31. Hendrich, B. and Tweedie, S. (2003) The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet., 19, 269-277. (Pubitemid 36507009)
32. Albalat, R. (2008) Evolution of DNA-methylation machinery: DNA methyltransferases and methyl-DNA binding proteins in the amphioxus branchiostoma floridae. Dev. Genes Evol., 218, 691-701.
33. Matsumoto, M. and Toraya, T. (2008) cDNA cloning, expression and characterization of methyl-CpG-binding domain type 2/3 proteins from starfish and sea urchin. Gene, 420, 125-134.
34. Springer, N.M. and Kaeppler, S.M. (2005) Evolutionary divergence of monocot and dicot methyl-CpG-binding domain proteins. Plant Physiol., 138, 92-104. (Pubitemid 43138110)
35. Sansom, O.J., Maddison, K. and Clarke, A.R. (2007) Mechanisms of disease: Methyl-binding domain proteins as potential therapeutic targets in cancer. Nat. Clin. Prac. Oncol., 4, 305-315. (Pubitemid 46758788)
36. Cai, M., Williams, D.C. Jr, Wang, G., Lee, B.R., Peterkofsky, A. and Clore, G.M. (2003) Solution structure of the phosphoryl transfer complex between the signal-transducing protein IIAGlucose and the cytoplasmic domain of the glucose transporter IICBGlucose of the Escherichia coli glucose phosphotransferase system. J. Biol. Chem., 278, 25191-25206. (Pubitemid 37548684)
37. Iwahara, J., Anderson, D.E., Murphy, E.C. and Clore, G.M. (2003) EDTA-derivatized deoxythymidine as a tool for rapid determination of protein binding polarity to DNA by intermolecular paramagnetic relaxation enhancement. J. Am. Chem. Soc., 125, 6634-6635. (Pubitemid 36667439)
38. Iwahara, J., Schwieters, C.D. and Clore, G.M. (2004) Ensemble approach for NMR structure refinement against (1)H paramagnetic relaxation enhancement data arising from a flexible paramagnetic group attached to a macromolecule. J. Am. Chem. Soc., 126, 5879-5896. (Pubitemid 38621427)
39. Iwahara, J. and Clore, G.M. (2006) Detecting transient intermediates in macromolecular binding by paramagnetic NMR. Nature, 440, 1227-1230.
40. Schwieters, C.D., Kuszewski, J.J., Tjandra, N. and Clore, G.M. (2003) The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson., 160, 65-73.
41. Clore, G.M. and Gronenborn, A.M. (1998) New methods of structure refinement for macromolecular structure determination by NMR. Proc. Natl Acad. Sci. USA, 95, 5891-5898. (Pubitemid 28248936)
42. Clore, G.M. and Kuszewski, J. (2002) Chi(1) rotamer populations and angles of mobile surface side chains are accurately predicted by a torsion angle database potential of mean force. J. Am. Chem. Soc., 124, 2866-2867. (Pubitemid 34249951)
43. Kuszewski, J., Gronenborn, A.M. and Clore, G.M. (1999) Improving the packing and accuracy of NMR structures with a pseudopotential for the radius of gyration. J. Am. Chem. Soc., 121, 2337-2338. (Pubitemid 29152461)
44. Cornilescu, G., Delaglio, F. and Bax, A. (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR, 13, 289-302. (Pubitemid 29143535)
45. Shen, Y., Delaglio, F., Cornilescu, G. and Bax, A. (2009) TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR, 44, 213-223.
46. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J. and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR, 6, 277-293.
47. Lipari, G. and Szabo, A. (1982) Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules 2. analysis of experimental results. J. Am. Chem. Soc., 104, 4559-4570.
48. Lipari, G. and Szabo, A. (1982) Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules 1. theory and range of validity. J. Am. Chem. Soc., 104, 4546-4559.
49. Clore, G.M., Szabo, A., Bax, A., Kay, L.E., Driscoll, P.C. and Gronenborn, A.M. (1990) Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteins. J. Am. Chem. Soc., 112, 4989-4991. (Pubitemid 20285925)
50. Mandel, A.M., Akke, M. and Palmer, A.G. 3rd (1995) Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme. J. Mol. Biol., 246, 144-163.
51. Clore, G.M., Tang, C. and Iwahara, J. (2007) Elucidating transient macromolecular interactions using paramagnetic relaxation enhancement. Curr. Opin. Struct. Biol., 17, 603-616. (Pubitemid 350019011)
52. Saito, M. and Ishikawa, F. (2002) The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem., 277, 35434-35439.
53. Clore, G.M., Tang, C. and Iwahara, J. (2007) Elucidating transient macromolecular interactions using paramagnetic relaxation enhancement. Curr. Opin. Struct. Biol., 17, 603-616. (Pubitemid 350019011)
54. Luscombe, N.M., Laskowski, R.A. and Thornton, J.M. (2001) Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Res., 29, 2860-2874. (Pubitemid 32685051)
55. Denslow, S.A. and Wade, P.A. (2007) The human Mi-2/NuRD complex and gene regulation. Oncogene, 26, 5433-5438. (Pubitemid 47255925)
56. Le Guezennec, X., Vermeulen, M., Brinkman, A.B., Hoeijmakers, W.A., Cohen, A., Lasonder, E. and Stunnenberg, H.G. (2006) MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol. Cell. Biol., 26, 843-851. (Pubitemid 43146480)
57. Brehm, A., Längst, G., Kehle, J., Clapier, C.R., Imhof, A., Eberharter, A., Müller, J. and Becker, P.B. (2000) dMi-2 and ISWI chromatin remodelling factors have distinct nucleosome binding and mobilization properties. EMBO J., 19, 4332-4341. (Pubitemid 30623744)
58. Schnitzler, G.R. (2008) Control of nucleosome positions by DNA sequence and remodeling machines. Cell Biochem. Biophys., 51, 67-80.
59. Clapier, C.R. and Cairns, B.R. (2009) The biology of chromatin remodeling complexes. Annu. Rev. Biochem., 78, 273-304.
60. Bowman, G.D. (2010) Mechanisms of ATP-dependent nucleosome sliding. Curr. Opin. Struct. Biol., 20, 73-81.
61. Ghosh, R.P., Horowitz-Scherer, R.A., Nikitina, T., Gierasch, L.M. and Woodcock, C.L. (2008) Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions. J. Biol. Chem., 283, 20523-20534.
62. Basse, N., Kaar, J.L., Settanni, G., Joerger, A.C., Rutherford, T.J. and Fersht, A.R. (2010) Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant. Chem. Biol., 17, 46-56.
63. Boeckler, F.M., Joerger, A.C., Jaggi, G., Rutherford, T.J., Veprintsev, D.B. and Fersht, A.R. (2008) Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proc. Natl Acad. Sci. USA, 105, 10360-10365.
64. Joerger, A.C. and Fersht, A.R. (2007) Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene, 26, 2226-2242. (Pubitemid 46536643)
65. Schwieters, C.D. and Clore, G.M. (2001) The VMD-XPLOR visualization package for NMR structure refinement. J. Magn. Reson., 149, 239-244.